Raymond James & Associates Glaukos Corp Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Glaukos Corp stock. As of the latest transaction made, Raymond James & Associates holds 13,966 shares of GKOS stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,966
Previous 13,017
7.29%
Holding current value
$1.42 Million
Previous $1.54 Million
18.12%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding GKOS
# of Institutions
355Shares Held
47.9MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$820 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$609 Million0.02% of portfolio
-
State Street Corp Boston, MA2.06MShares$210 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$197 Million0.08% of portfolio
-
Invesco Ltd. Atlanta, GA1.46MShares$149 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.85B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...